Order Article Reprints

Botti G, Federico F, Meliga E, Daemen J, D’Ascenzo F, Capodanno D, Dumonteil N, Tchetche D, Van Mieghem NM, Nakamura S, et al. Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes from a Subanalysis of the Delta 2 Registry. Journal of Cardiovascular Development and Disease. 2025; 12(5):179. https://doi.org/10.3390/jcdd12050179

Botti, Giulia, Francesco Federico, Emanuele Meliga, Joost Daemen, Fabrizio D’Ascenzo, Davide Capodanno, Nicolas Dumonteil, Didier Tchetche, Nicolas M. Van Mieghem, Sunao Nakamura, and et al. 2025. "Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes from a Subanalysis of the Delta 2 Registry" Journal of Cardiovascular Development and Disease 12, no. 5: 179. https://doi.org/10.3390/jcdd12050179

Botti, G., Federico, F., Meliga, E., Daemen, J., D’Ascenzo, F., Capodanno, D., Dumonteil, N., Tchetche, D., Van Mieghem, N. M., Nakamura, S., Garot, P., Erglis, A., Vella, C., Tamburino, C., Morice, M. C., Mehran, R., Montorfano, M., & Chieffo, A. (2025). Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes from a Subanalysis of the Delta 2 Registry. Journal of Cardiovascular Development and Disease, 12(5), 179. https://doi.org/10.3390/jcdd12050179